Evidence map›Paper›PMID 41053031›Full record

ArticleTranslational psychiatry2025

TGR5 dysfunction underlies chronic social defeat stress via cAMP/PKA signaling pathway in the hippocampus.

Xiangyu Chen, Qinji Zhou, Yong He, Yue Wang, Yanyi Jiang, Yi Ren, Yikun Ren, Junchao Cai, Heming Yu, Chong Chen and 2 more

Abstract read
In one paragraph

Article in Translational psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xiangyu Chen *National Health Commission Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Qinji Zhou *National Health Commission Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yong He *National Health Commission Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yue WangNational Health Commission Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yanyi JiangNational Health Commission Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yi RenNational Health Commission Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yikun RenNational Health Commission Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Junchao CaiNational Health Commission Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Heming YuNational Health Commission Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Chong ChenNational Health Commission Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Ke ChengNational Health Commission Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Peng XieNational Health Commission Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. xiepeng@cqmu.edu.cn.ORCID http://orcid.org/0000-0002-0081-6048

Funding

Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) 2017YFA0505700
6 · The paper itself

Abstract

Major depressive disorder (MDD) is a debilitating mental health disorder that has a wide impact on many patients and has imposed a heavy burden on society in recent years. However, the specific pathogenesis of depression remains to be elucidated. Numerous studies have shown that metabolic disorders and molecules play important roles in MDD. Here, we demonstrate a preliminary mechanism through which TGR5 functions in the hippocampus during bile acid synthesis dysfunction in mice subjected to chronic social defeat stress (CSDS). According to the enzyme-linked immunosorbent assay (ELISA), susceptible mice subjected to CSDS presented reduced expression of key bile acid enzymes in the serum and total bile acids (TBAs) in the hippocampus. The expression of the bile acid-related receptor TGR5 in the hippocampus was lower in CSDS-exposed susceptible mice than in control mice. By analyzing the potential downstream signaling pathways of TGR5, we found that specific TGR5/cAMP/PKA regulation effectively increased the plasticity of Schaffer collateral (SC)-CA1 synapses in the hippocampus and further alleviated anxiety- and depression-like behavior in susceptible mice. These findings suggest that CSDS susceptibility is accompanied by dysfunction of TGR5 in the hippocampus and the downstream cAMP/PKA signaling pathway. Activating cAMP/PKA signaling can ameliorate behavioral deficits in susceptible mice. This study may support the development of potential effective pharmacotherapies for the treatment of MDD.

Indexed as

Cyclic AMPCyclic AMP-Dependent Protein KinasesHippocampusMajor Depressive DisorderReceptors, G-Protein-CoupledSocial DefeatStress, PsychologicalAnimalsBehavior, AnimalBile Acids and SaltsDisease Models, AnimalMaleMiceMice, Inbred C57BLSignal TransductionBile Acids and SaltsCyclic AMPCyclic AMP-Dependent Protein KinasesGpbar1 protein, mouseReceptors, G-Protein-Coupled

Identifiers

PMID41053031
PMCPMC12501386

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.